Top 10 VC medical device deals H2 2011

There has been a lot of talk in biopharma circles about the decline of venture capital funding. But as we can see from this report in FierceMedicalDevices, there are medtech companies raking in cash. What are the hot companies receiving top backing? We look at the top 10 deals from the second half of 2011. Report

Suggested Articles

A who’s who of Big Pharmas, including Pfizer, Johnson & Johnson and Merck, have banded together to bolster the development of new antibiotics.

Bayer's finerenone beat placebo at slowing kidney disease and cut the risk of heart attacks and strokes in diabetic kidney disease patients.

The National Institute of Allergy and Infectious Diseases is launching a new clinical trials network for COVID-19.